04:12 AM EDT, 07/29/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & Chief Executive Officer, on July 23, 2024, sold 7,200 shares in United Therapeutics ( UTHR ) for $2,409,782. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 646,231 shares of the company, with 130 shares held directly and 646,101 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1082554/000141588924020102/xslF345X03/form4-07252024_040701.xml